Drug intelligence / Profile preview

isotretinoin

Development stage
Approved
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Isotretinoin is a retinoid derivative of vitamin A used primarily to treat severe recalcitrant nodular acne that has not responded to other treatments such as antibiotics. It is also known as 13-cis-retinoic acid. Isotretinoin works by inducing apoptosis in sebocytes (cells in the sebaceous glands), leading to reduced sebum production and decreased formation of comedones. This action helps prevent pore blockage and reduces the growth of acne-causing bacteria. The drug alters cell cycle progression and differentiation but does not directly kill bacteria; instead it changes the skin environment to be less hospitable for them. Isotretinoin is highly teratogenic and available only under strict risk management programs like iPLEDGE due to its potential for causing severe birth defects[1][2][3][4][5][6][8]. Off-label uses include treatment of certain rare skin disorders such as harlequin-type ichthyosis and lamellar ichthyosis[5].

Brand names
AbsoricaAbsorica LDAccutaneAmnesteemClaravisClarusEpurisMyorisanSotretZenatane
Other names
13-cis-retinoic acid
02

Targets

RARA (Retinoic acid receptor alpha)RXRA (Retinoid X receptor alpha)RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)

Beyond the preview

Go deeper on isotretinoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isotretinoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call